Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines through base editing [3] - The company aims to establish a leading, fully integrated platform for precision genetic medicines, incorporating gene editing and delivery technologies [3] - Beam's proprietary base editing technology allows for precise, predictable, and efficient single base changes in targeted genomic sequences without causing double-stranded breaks in DNA [3] Upcoming Events - John Evans, the CEO of Beam Therapeutics, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, at 1:30 p.m. PT in San Francisco [1] - A live webcast of the presentation will be available on the company's investor section of the website and archived for 60 days [2]